Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 2 1Phase 1/2 1Phase 1 1

Status

Recruiting 5Active not recruiting 2Completed 1

Sponsor Class

OTHER 5INDUSTRY 2NETWORK 1

Study Type

Interventional 8Observational 1

Sponsor

Cancer Type

Genitourinary 8

Conditions

Breast Neoplasms 2419Neoplasms 1838Carcinoma, Non-Small-Cell Lung 1591Prostatic Neoplasms 1296Colorectal Neoplasms 1117Lung Neoplasms 981Neoplasm Metastasis 828Multiple Myeloma 793Leukemia, Myeloid, Acute 773Ovarian Neoplasms 673Pancreatic Neoplasms 667Melanoma 660Squamous Cell Carcinoma of Head and Neck 589Recurrence 563Carcinoma, Hepatocellular 562Brain Neoplasms 515Glioblastoma 505Stomach Neoplasms 501Head and Neck Neoplasms 492Triple Negative Breast Neoplasms 471Lymphoma 460Uterine Cervical Neoplasms 444Carcinoma, Renal Cell 426Precursor Cell Lymphoblastic Leukemia-Lymphoma 420Lymphoma, Non-Hodgkin 387Endometrial Neoplasms 377Sarcoma 365Lymphoma, Follicular 357Urinary Bladder Neoplasms 356Lymphoma, Large B-Cell, Diffuse 355

Interventions

Radiosurgery 3Androgen Antagonists 3Prednisone 2Docetaxel 2Abiraterone Acetate 2fludrocortisone acetate 1enzalutamide 1darolutamide 1apalutamide 1Standard of Care 1Radiotherapy, Image-Guided 1Radiotherapy 1Pluvicto 1Midazolam 1Lutetium-177 1Lutetium 1Hydrocortisone 1Gonadotropin-Releasing Hormone 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Interventional × Prostate Cancer Metastatic × 1 year × Clear all
NCT06136624 2026-05-05

OMAHA-003

Merck Sharp & Dohme LLC

Phase 3 Recruiting
1,310 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT04916613 2026-04-28

GETUG-AFU 40

UNICANCER

Phase 3 Recruiting
300 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT02913196 2026-04-20

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Weill Medical College of Cornell University

Phase 1 Completed
16 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT05457699 2026-04-08

ANCHORProstate

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Recruiting
80 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT03784755 2026-03-27

PLATON

Canadian Cancer Trials Group

Phase NA Active not recruiting
409 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT04983095 2026-02-17

METRO

Umeå University

Phase NA Recruiting
118 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT06320067 2025-09-26

STAMPEDE2

University College, London

Phase 3 Recruiting
3,360 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT03436485 2025-07-22

CYPIDES

Orion Corporation, Orion Pharma

Phase 1/2 Active not recruiting
204 enrolled
Genitourinary

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡